Importantly, bortezomib-mediated sensitization for TRAIL-induced cell death was not restricted to HCT116 PIK3CA-mut cells but also occurred in the PIK3CA-mutant CRC cell lines LS-174T and DLD-1. The gene discussed is PIK3CA; the disease is colorectal carcinoma.